ZERO Prostate Cancer (ZERO) announces the 2026 ZERO Prostate Cancer Advocacy Summit will take place in person at the Hilton Washington, D.C. Capitol Hill, just steps away from the offices of the ...

AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...

Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

IOWA CITY, Iowa (KWQC) -Prostate cancer remains the most common non-skin cancer in men and the second deadliest after lung cancer, according to the American Association of Cancer Research. As part of ...

Cancer caregiving can be taxing in many ways, from physical to emotional, as well as on the caregiver's time and resources. Here's how to help prevent burnout getty According to the American Cancer ...

Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small ...

Prostate cancer has been one of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

If you or a loved one has been diagnosed with prostate cancer, you’re not alone—and you don’t have to wait long to take the next step. Whether you’re newly diagnosed, moving from active surveillance ...